Home› Procurement News - Sweden FDA approves once-weekly efanesoctocog alfa a new class of high-sustained factor VIII therapy for haemophilia A, Sweden (485008659)

Procurement News

Procurement News
News TI Ref No
485008659
News Date
25 Feb 2023
News Description
Sweden FDA approves once-weekly efanesoctocog alfa a new class of high-sustained factor VIII therapy for haemophilia A
Tender Deadline
⏰ 25 Feb 2023 Closing soon
News Project Location
Sweden
News Sector
Healthcare & Medical - Medical Tenders
News Document Type
Procurement News
Tender Organization Name
🔒 Members only Click for more details
Tender Organization Name
🔒 Members only Click for more details
Tender Organization Name
🔒 Members only Click for more details
Unlock Full Details — Register Free
Start with receiving Free Data Samples related to your Products and Services
✓
Live Tender Updates from worldwide
✓
Access to original Tender Documents
✓
Information on Upcoming Projects & Contract Awards
✓
Bid Assistance Services
✓
Competitor Analysis & Industry Trends
✓
Daily Custom Email Alerts by Sector & Country

Similar News

View All Healthcare & Medical - Medical Tenders Tenders ->

Register to View Tenders

Start Your Business Journey. Register now for 3 days Free Sample Tenders & AI Website Demo.

Already have an account? Login here

By registering you agree to our Terms & Conditions and Privacy Policy.